Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse Development

REFERENCES

• Angerer, L. M., and R. C. Angerer. 1991. Localizations of mRNAs by in situ hybridisation. Methods Cell Biol. 35: 37–71.
   PubMedGoogle Scholar
• Aolad, H. M., M. Inouye, W. Darmanto, S. Hayasaka, and Y. Marata. 2000. Hydrocephalus in mice following X-irradiation at early gestational stage, possibly due to persistent deceleration of cell proliferation. J. Radiat. Res. 41: 213–226.
   PubMedGoogle Scholar
• Boyd, S. D., K. Y. Tsai, and T. Jacks. 2000. An intact HDM2 RING-finger domain is required for nuclear exclusion of p53. Nat. Cell Biol. 2: 563–568.
   PubMed Web of Science ®Google Scholar
• Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552–557.
   PubMed Web of Science ®Google Scholar
• Daujat, S., H. Neel, and J. Piette. 2001. MDM2: life without p53. Trends Genet. 17: 459–464.
   PubMedGoogle Scholar
• Deng, C., P. Zhang, J. W. Harper, S. J. Elledge, and P. Leder. 1995. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675–684.
   PubMed Web of Science ®Google Scholar
• Geyer, R. K., Z. K. Yu, and C. G. Maki. 2000. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2: 569–573.
   PubMed Web of Science ®Google Scholar
• Hall, P. A., and D. P. Lane. 1997. Tumour suppressors: a developing role for p53? Curr. Biol. 7: 144–147.
   PubMedGoogle Scholar
• Harvey, M., A. T. Sands, R. S. Weiss, M. E. Hegi, R. W. Wiseman, P. Pantazis, B. G. Giovanella, M. A. Tainsky, A. Bradley, and L. A. Donehower. 1993. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 8: 2457–2467.
   PubMed Web of Science ®Google Scholar
• Jacks, T., L. Remington, B. O. Williams, E. M. Schmitt, S. Halachmi, R. T. Bronson, and R. A. Weinberg. 1994. Tumor spectrum analysis in p53 mutant mice. Curr. Biol. 4: 1–7.
   PubMed Web of Science ®Google Scholar
• Jackson, M. W., and S. J. Berberich. 2000. Mdmx protects p53 from Mdm2-mediated degradation. Mol. Cell. Biol. 20: 1001–1007.
   PubMed Web of Science ®Google Scholar
• Jones, S. N., A. E. Roe, L. A. Donehower, and A. Bradley. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206–208.
   PubMed Web of Science ®Google Scholar
• Jones, S. N., A. T. Sands, A. R. Hancock, H. Vogel, L. A. Donehower, S. P. Linke, G. M. Wahl, and A. Bradley. 1996. The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2. Proc. Natl. Acad. Sci. USA 93: 14106–14111.
   PubMed Web of Science ®Google Scholar
• Kadia, M., C. Slader, and S. J. Berberich. 2001. Regulation of p63 function by Mdm2 and Mdmx. DNA Cell Biol. 20: 321–330.
   PubMedGoogle Scholar
• Koff, A., A. Giordano, D. Desai, K. Yamashita, J. W. Harper, S. Elledge, T. Nishimoto, D. O. Morgan, B. R. Franza, and J. M. Roberts. 1992. Formation and activation of cyclin E/CDK2 complex during the G1 phase of the human cell cycle. Science 257: 1689–1694.
   PubMed Web of Science ®Google Scholar
• Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88: 323–331.
   PubMed Web of Science ®Google Scholar
• MacCallum, D. E., T. R. Hupp, C. A. Midgley, D. Stuart, S. J. Campbell, A. Harper, F. S. Walsh, E. G. Wright, A. Balmain, D. P. Lane, and P. A. Hall. 1996. The p53 response to ionising radiation in adult and developing murine tissues. Oncogene 13: 2575–2587.
   PubMed Web of Science ®Google Scholar
• Migliorini, D., D. Danovi, E. Colombo, R. Carbone, P. G. Pelicci, and J.-C. Marine. 2002. Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. J. Biol. Chem. 277: 7318–7323.
   PubMed Web of Science ®Google Scholar
• Miller, F. D., C. D. Pozniak, and G. S. Walsh. 2000. Neuronal life and death: an essential role for the p53 family. Cell Death Differ. 7: 880–888.
   PubMed Web of Science ®Google Scholar
• Montes de Oca Luna, R., D. S. Wagner, and G. Lozano. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by absence of p53. Nature 378: 203–206.
   PubMed Web of Science ®Google Scholar
• Nicholson, D. W., A. Ali, N. A. Thornberry, J. P. Vaillancourt, C. K. Ding, M. Gallant, Y. Gareau, P. R. Griffin, M. Labelle, Y. A. Lazebnik, et al. 1995. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376: 37–43.
   PubMed Web of Science ®Google Scholar
• Ohtsubo, M., and J. M. Roberts. 1993. Cyclin dependent regulation of G1 in mammalian fibroblasts. Science 59: 1908–1912.
   Google Scholar
• Ohtsubo, M., A. M. Theodoras, J. Schumacher, J. M. Roberts, and M. Pagano. 1995. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell. Biol. 15: 2612–2624.
   PubMed Web of Science ®Google Scholar
• Ongkeko, W. M., X. Q. Wang, W. Y. Siu, A. W. Lau, K. Yamashita, A. L. Harris, L. S. Cox, and R. Y. Poon. 1999. MDM2 and MDMX bind and stabilize the p53-related protein p73. Curr. Biol. 9: 829–832.
   PubMedGoogle Scholar
• Parant, J., A. Chavez-Reyes, N. A. Little, W. Yan, V. Reinke, A. G. Jochemsen, and G. Lozano. 2001. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a non-overlapping pathway with MDM2 to regulate p53. Nat. Genet. 29: 92–95.
   PubMed Web of Science ®Google Scholar
• Ramos, Y. F., R. Stad, J. Attema, L. T. Peltenburg, A. J. van der Eb, and A. G. Jochemsen. 2001. Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53. Cancer Res. 61: 1839–1842.
   PubMed Web of Science ®Google Scholar
• Roth, J., M. Dobbelstein, D. A. Freedman, T. Shenk, and A. J. Levine. 1998. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. EMBO J. 17: 554–564.
   PubMed Web of Science ®Google Scholar
• Samuels-Lev, Y., D. J. O'Connor, D. Bergamaschi, G. Trigiante, J. K. Hsieh, S. Zhong, I. Campargue, L. Naumovski, T. Crook, and X. Lu. 2001. ASSP proteins specifically stimulate the apoptotic function of p53. Mol. Cell 8: 781–794.
   PubMed Web of Science ®Google Scholar
• Sharp, D. A., S. A. Kratowicz, M. J. Sank, and D. L. George. 1999. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein. J. Biol. Chem. 274: 38189–38196.
   PubMed Web of Science ®Google Scholar
• Shvarts, A., W. T. Steegenga, N. Riteco, T. van Laar, P. Dekker, M. Bazuine, R. C. van Ham, W. van der Houven van Oordt, G. Hateboer, A. J. van der Eb, and A. G. Jochemsen. 1996. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J. 15: 5349–5357.
   PubMed Web of Science ®Google Scholar
• Shvarts, A., M. Bazuine, P. Dekker, Y. F. Ramos, W. T. Steegenga, G. Merckx, R. C. van Ham, W. van der Houven van Oordt, A. J. van der Eb, and A. G. Jochemsen. 1997. Isolation and identification of the human homolog of a new p53-binding protein, Mdmx. Genomics 43: 34–42.
   PubMed Web of Science ®Google Scholar
• Stad, R., N. A. Little, D. P. Xirodimas, R. Frenk, A. J. van der Eb, D. P. Lane, M. K. Saville, and A. G. Jochemsen. 2000. Hdmx stabilizes Mdm2 and p53. J. Biol. Chem. 275: 28039–28044.
   PubMed Web of Science ®Google Scholar
• Stad, R., Y. F. Ramos, N. Little, S. Grivell, J. Attema, A. J. van Der Eb, and A. G. Jochemsen. 2001. Mdmx stabilizes p53 and Mdm2 via two distinct mechanisms. EMBO Rep. 2: 1029–1034.
   PubMed Web of Science ®Google Scholar
• Tanimura, S., S. Ohtsuka, K. Mitsui, K. Shirouzu, A. Yoshimura, and M. Ohtsubo. 1999. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett. 447: 5–9.
   PubMed Web of Science ®Google Scholar
• Tao, W., and A. J. Levine. 1999. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl. Acad. Sci. USA 96: 3077–3080.
   PubMed Web of Science ®Google Scholar
• Vousden, K. H. 2000. p53: death star. Cell 103: 691–694.
   PubMed Web of Science ®Google Scholar
• Yam, C. H., W. Y. Siu, T. Arooz, C. H. Chiu, A. Lau, X. Q. Wang, and R. Y. Poon. 1999. MDM2 and MDMX inhibit the transcriptional activity of ectopically expressed SMAD proteins. Cancer Res. 59: 5075–5078.
   PubMed Web of Science ®Google Scholar
• Zambrowicz, B. P., G. A. Friedrich, E. C. Buxton, S. L. Lilleberg, C. Person, and A. T. Sands. 1998. Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells. Nature 392: 608–611.
   PubMed Web of Science ®Google Scholar